Cyclerion Therapeutics
CYCN
CYCN
18 hedge funds and large institutions have $4.1M invested in Cyclerion Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 18
Holders
18
Holding in Top 10
–
Calls
$573K
Puts
–
Top Buyers
| 1 | +$55.1K | |
| 2 | +$3K | |
| 3 | +$911 | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$452 |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$94 |
Top Sellers
| 1 | -$50.1K | |
| 2 | -$49.9K | |
| 3 | -$44K | |
| 4 |
Renaissance Technologies
New York
|
-$38K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$35.1K |